HITLAB, a global leader in digital health innovation and evidence generation, announced a strategic partnership with Immunogenik, Inc., a biotechnology company developing novel therapeutic platforms for aggressive cancers such as glioblastoma (GBM) and lung cancer brain metastasis.
In a groundbreaking collaboration poised to elevate global standards for digital maternal health, HITLAB, a world leader in evidence-based digital-health research, has partnered with BobiHealth, an award-winning pregnancy companion platform recognized as a Top Pregnancy Health Tracking Tool of 2025.
Daily newsletter roundup from HITLAB of the latest in digital health news
Daily newsletter roundup from HITLAB of the latest in digital health news
Daily newsletter roundup from HITLAB of the latest in digital health news
Daily newsletter roundup from HITLAB of the latest in digital health news


